Speaker Profile
M.D., Radiologist, UCSF
Biography
Thomas Hope, MD is a radiologist and nuclear medicine physician. He is the Vice Chair of Clinical Operations and Strategy in the Department of Radiology, and serves as the Director of Molecular Therapy. Dr. Hopes main research focus is on novel imaging agents and therapies, particularly in prostate cancer and neuroendocrine tumors. He lead the development of Ga-68 PSMA-11, which subsequently led to the approval of this drug by the FDA. He has combined his interest in MR imaging with PET in the simultaneous modality PETMRI, helping lead the development of the clinical PETMRI program. Additionally he leads the PRRT (peptide receptor radionuclide therapy) program for neuroendocrine tumors and PSMA Radioligand Therapy at UCSF.
Session Abstract – PMWC 2025 Silicon Valley
Track Chair: Razelle Kurzrock, Medical College of Wisconsin
- PMWC 2025 Award Ceremony:
Luminary Honoree: Hedvig Hricak, Memorial Sloan Kettering
Pioneer Honoree: Michael E. Phelps, UCLA - Keynote: Precision Imaging for Precision Medicine
- Hedvig Hricak, Memorial Sloan Kettering
- Keynote: PET Imaging and Theranostics: Revolutionizing Cancer Detection and Treatment
- Michael E. Phelps, UCLA
- Radiopharmaceuticals for Cancer Therapy
Chair: Wiliam Oh, Mount Sinai
- Naga Vara Kishore Pillarsetty, Memorial Sloan Kettering
- Jones Nauseef, Convergent Therapeutics
- Thomas Hope, UCSF
- Advancements in Digital Imaging: Enhancing Accuracy in Cancer Diagnostics
Chair: Razelle Kurzrock, Medical College of Wisconsin
- Hedvig Hricak, Memorial Sloan Kettering
- Liron Pantanowitz, University of Pittsburgh
- Eliot Siegel, VA Maryland Healthcare System
- Sharmila Majumdar, UCSF
- Wafik El-Deiry, Brown University - Digitalizing Oncology Care: Challenges and Opportunities
Chair: Christian Wolfrum Siemens Healthineers
- Ashley Smith, Varian
- Marshall Pitz, Manitoba Cancer Care
- PMWC Showcase: Informing Patient Treatment Decisions using Advanced Molecular Diagnostics
- Matthew Goldberg, Castle Bio
- Navigating Regulatory Hurdles and Reimbursement Pathways for Oncology Innovations
Chair: Sheila Walcoff, Goldbug Strategies
- Gabriel A. Bien-Willner, Palmetto GBA
